Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer-Reference-Cited by-同舟云学术

Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer

Published:2018-11 Issue:5 Volume:28 Page:679-688.e4
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Lord Simon R.,Cheng Wei-Chen,Liu Dan,Gaude Edoardo,Haider Syed,Metcalf Tom,Patel Neel,Teoh Eugene J.,Gleeson Fergus,Bradley Kevin,Wigfield Simon,Zois Christos,McGowan Daniel R.,Ah-See Mei-Lin,Thompson Alastair M.,Sharma Anand,Bidaut Luc,Pollak Michael,Roy Pankaj G.,Karpe Fredrik,James Tim,English Ruth,Adams Rosie F.,Campo Leticia,Ayers Lisa,Snell Cameron,Roxanis Ioannis,Frezza Christian,Fenwick John D.,Buffa Francesca M.,Harris Adrian L.

Funder

Oxford Cancer Imaging Centre

NIHR Oxford Biomedical Research Centre

Breast Cancer Research Foundation

Medical Research Council

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference39 articles.

1. Differential expression analysis for sequence count data;Anders;Genome Biol.,2010

2. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells;Ben Sahra;Cancer Res.,2010